T1	PROC 18 29	tratamiento
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 36 67	sepsis neonatal por enterovirus
T3	CHEM 1362 1369	fórmula
#2	AnnotatorNotes T3	C0012164; Formula - diet; Therapeutic or Preventive Procedure
T4	LIVB 87 97	prematuros
#3	AnnotatorNotes T4	C4048294; Preterm Infant; Age Group
T5	CHEM 1618 1632	cardiotrópicos
T6	DISO 216 248	enfermedad grave por enterovirus
T7	DISO 290 296	sepsis
T8	DISO 312 323	miocarditis
#4	AnnotatorNotes T8	C0027059; Myocarditis; Disease or Syndrome
T9	DISO 325 337	coagulopatía
#5	AnnotatorNotes T9	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T10	DISO 339 357	meningoencefalitis
#6	AnnotatorNotes T10	C0025309; Meningoencephalitis; Disease or Syndrome
T11	DISO 362 372	neumonitis
#7	AnnotatorNotes T11	C0032285; Pneumonia; Disease or Syndrome | C3714636; Pneumonitis; Disease or Syndrome
T12	CHEM 428 447	compuesto antiviral
T13	ANAT 1132 1150	gastrointestinales
#8	AnnotatorNotes T13	C0012240; Gastrointestinal system; Body System
T14	PROC 1688 1704	soporte avanzado
#9	AnnotatorNotes T14	C0419055; Advanced life support; Therapeutic or Preventive Procedure
T15	ANAT 559 566	celular
#10	AnnotatorNotes T15	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T16	PROC 577 598	Estudio multicéntrico
#11	AnnotatorNotes T16	C1096776; Multicenter Study; Research Activity
T17	PROC 628 692	Ensayo con asignación aleatoria, doble-ciego, placebo controlado
#12	AnnotatorNotes T17	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product
T18	DISO 1076 1079	VIH
#13	AnnotatorNotes T18	C0458074; Human immunodeficiency virus (HIV) status; Finding
T19	CHEM 1917 1927	pleconaril
#14	AnnotatorNotes T19	C0759032; pleconaril; Organic Chemical · Pharmacologic Substance
T20	DISO 739 749	enfermedad
#15	AnnotatorNotes T20	C0012634; Disease; Disease or Syndrome
T21	DISO 847 869	sepsis por enterovirus
T22	ANAT 912 920	hepático
#16	AnnotatorNotes T22	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T23	ANAT 925 939	cardiovascular
#17	AnnotatorNotes T23	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T24	DISO 1002 1022	infección bacteriana
#18	AnnotatorNotes T24	C0004623; Bacterial Infections; Disease or Syndrome
T25	DISO 1031 1050	infecciones virales
#19	AnnotatorNotes T25	C0042769; Virus Diseases; Disease or Syndrome
T26	DISO 1085 1116	cardiopatía congénita cianótica
#20	AnnotatorNotes T26	C0265808; Cyanotic congenital heart disease; Disease or Syndrome
T27	DISO 1119 1150	alteraciones gastrointestinales
#21	AnnotatorNotes T27	C0232459; Abnormal digestive tract function; Finding
T28	DISO 1203 1213	enfermedad
#22	AnnotatorNotes T28	C0012634; Disease; Disease or Syndrome
T29	ANAT 1375 1379	boca
#23	AnnotatorNotes T29	C0226896; Oral cavity; Body Space or Junction | C0230028; Oral region; Body Location or Region | C1267547; Entire mouth region; Body Space or Junction
T30	PROC 1415 1423;1433 1449	cultivos para enterovirus
#24	AnnotatorNotes T30	C1294248; Enterovirus culture; Laboratory Procedure
T31	ANAT 1453 1463	orofaringe
#25	AnnotatorNotes T31	C0521367; Oropharyngeal; Body Location or Region | C1280659; Entire oropharynx; Body Part, Organ, or Organ Component
T32	ANAT 1465 1470	recto
#26	AnnotatorNotes T32	C0034896; Rectum; Body Part, Organ, or Organ Component | C1278926; Entire rectum; Body Part, Organ, or Organ Component
T33	ANAT 1480 1485	suero
#27	AnnotatorNotes T33	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T34	CHEM 1543 1563	fármacos antivirales
#28	AnnotatorNotes T34	C0003451; Antiviral Agents; Pharmacologic Substance
T35	CHEM 1575 1584	aciclovir
#29	AnnotatorNotes T35	C0001367; acyclovir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T36	CHEM 1634 1649	antibacterianos
#30	AnnotatorNotes T36	C0279516; Anti-Bacterial Agents; Antibiotic
T37	CHEM 1651 1666	inmunoglobulina
#31	AnnotatorNotes T37	C0021027; Immunoglobulins; Amino Acid, Peptide, or Protein · Immunologic Factor
T38	CHEM 1680 1684	IGIV
#32	AnnotatorNotes T38	C1527233; Recombinant Immune Globulin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor (?)
T39	PROC 1758 1769	seguimiento
#33	AnnotatorNotes T39	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T40	PROC 1797 1810	Se ingresaron
#34	AnnotatorNotes T40	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T41	LIVB 1814 1816	RN
#35	AnnotatorNotes T41	C0021289; Infant, Newborn; Age Group
T42	DISO 1858 1884	enfermedad por enterovirus
#36	AnnotatorNotes T42	C0014378; Enterovirus Infections; Disease or Syndrome
T43	PROC 1942 1949	placebo
#37	AnnotatorNotes T43	C0032042; Placebos; Therapeutic or Preventive Procedure
T44	PROC 2023 2031	cultivos
#38	AnnotatorNotes T44	C0430400; Laboratory culture; Laboratory Procedure
T45	CHEM 2061 2071	pleconaril
#39	AnnotatorNotes T45	C0759032; pleconaril; Organic Chemical · Pharmacologic Substance
T46	PROC 2086 2093	placebo
#40	AnnotatorNotes T46	C0032042; Placebos; Therapeutic or Preventive Procedure
T47	PROC 2204 2211	placebo
#41	AnnotatorNotes T47	C0032042; Placebos; Therapeutic or Preventive Procedure
T49	CHEM 411 421	Pleconaril
#42	AnnotatorNotes T49	C0759032; pleconaril; Organic Chemical · Pharmacologic Substance
T50	PROC 2412 2420	tratados
#43	AnnotatorNotes T50	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T51	CHEM 2425 2435	pleconaril
#44	AnnotatorNotes T51	C0759032; pleconaril; Organic Chemical · Pharmacologic Substance
T52	CHEM 2473 2477	IVIG
#45	AnnotatorNotes T52	C1527233; Recombinant Immune Globulin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor (?)
T53	DISO 980 986	muerte
#46	AnnotatorNotes T53	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T54	CHEM 1152 1162	Pleconaril
#47	AnnotatorNotes T54	C0759032; pleconaril; Organic Chemical · Pharmacologic Substance
T55	ANAT 1472 1477	orina
#48	AnnotatorNotes T55	C0042036; Urine; Body Substance
T56	DISO 871 939	compromiso hematológico, de coagulación, hepático y/o cardiovascular
T57	CHEM 2147 2157	pleconaril
#49	AnnotatorNotes T57	C0759032; pleconaril; Organic Chemical · Pharmacologic Substance
T58	CHEM 1 11	Pleconaril
#50	AnnotatorNotes T58	C0759032; pleconaril; Organic Chemical · Pharmacologic Substance
T59	LIVB 56 67	enterovirus
#51	AnnotatorNotes T59	C0014383; Enterovirus; Virus
T60	LIVB 104 134	recién nacidos (RN) de término
#52	AnnotatorNotes T60	C4551581; Term Infant; Age Group
T62	Spec_cue 185 197	susceptibles
T63	LIVB 237 248	enterovirus
#53	AnnotatorNotes T63	C0014383; Enterovirus; Virus
T64	LIVB 250 252	EV
#54	AnnotatorNotes T64	C0014383; Enterovirus; Virus
T65	Spec_cue 262 267	puede
T66	LIVB 466 477	enterovirus
#55	AnnotatorNotes T66	C0014383; Enterovirus; Virus
T67	LIVB 480 489	rinovirus
#56	AnnotatorNotes T67	C0035473; Rhinovirus; Virus
T69	Neg_cue 521 531	impidiendo
T70	Duration 753 773	los primeros 15 días
T71	PHYS 804 815	gestacional
#57	AnnotatorNotes T71	C0032961; Pregnancy; Organism Function
T72	Duration 816 828	> 32 semanas
T73	Spec_cue 835 846	sospecha de
T74	LIVB 858 869	enterovirus
#58	AnnotatorNotes T74	C0014383; Enterovirus; Virus
T75	PHYS 899 910	coagulación
#59	AnnotatorNotes T75	C0005778; Blood coagulation; Organ or Tissue Function
T76	Neg_cue 942 955	Se excluyeron
T77	LIVB 956 965	pacientes
#60	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T78	Spec_cue 970 979	riesgo de
T80	Duration 1179 1199	los primeros 10 días
T81	Route 1233 1241	vía oral
#61	AnnotatorNotes T81	C1527415; Oral Route of Drug administration; Functional Concept
T82	Dose 1254 1261	5 mg/kg
T83	Dose 1286 1295	8,5 mg/kg
T84	Form 1297 1307	suspensión
#62	AnnotatorNotes T84	C4724031; Suspension Dosage Form; Biomedical or Dental Material
T85	Frequency 1322 1330	cada 8 h
T86	Duration 1335 1341	7 días
T87	LIVB 1438 1449	enterovirus
#63	AnnotatorNotes T87	C0014383; Enterovirus; Virus
T89	LIVB 1510 1519	pacientes
#64	AnnotatorNotes T89	C0030705; Patients; Patient or Disabled Group
T92	LIVB 1604 1615	enterovirus
#65	AnnotatorNotes T92	C0014383; Enterovirus; Virus
T93	Route 1667 1678	intravenosa
#66	AnnotatorNotes T93	C1522726; Intravenous Route of Drug Administration; Functional Concept
T94	Duration 1722 1729	11 años
T95	LIVB 1736 1745	pacientes
#67	AnnotatorNotes T95	C0030705; Patients; Patient or Disabled Group
T96	Duration 1773 1781	dos años
T97	LIVB 1873 1884	enterovirus
#68	AnnotatorNotes T97	C0014383; Enterovirus; Virus
T98	Duration 2100 2106	7 días
T99	LIVB 2243 2252	pacientes
#69	AnnotatorNotes T99	C0030705; Patients; Patient or Disabled Group
T102	LIVB 2385 2394	pacientes
#70	AnnotatorNotes T102	C0030705; Patients; Patient or Disabled Group
T104	Neg_cue 2470 2472	no
T108	PHYS 535 544	adsorción
#71	AnnotatorNotes T108	C3820692; virion attachment to host cell pilus; Cell Function (?)
T109	LIVB 1012 1022	bacteriana
#72	AnnotatorNotes T109	C0004611; Bacteria; Bacterium
T110	LIVB 1043 1050	virales
#73	AnnotatorNotes T110	C0042776; Virus; Virus
T61	Age 138 158	sus primeros 15 días
T68	PHYS 547 566	penetración celular
#74	AnnotatorNotes T68	C1656555; viral entry into host cell; Cell Function
T79	Form 1263 1282	formulación líquida
T88	DEVI 1382 1399	sonda orogástrica
#75	AnnotatorNotes T88	C3469032; og feeding tube; Medical Device
T90	LIVB 1886 1888	EV
#76	AnnotatorNotes T90	C0014383; Enterovirus; Virus
T91	LIVB 1932 1934	EV
#77	AnnotatorNotes T91	C0014383; Enterovirus; Virus
T106	LIVB 1954 1956	EV
#78	AnnotatorNotes T106	C0014383; Enterovirus; Virus
T107	LIVB 2257 2259	EV
#79	AnnotatorNotes T107	C0014383; Enterovirus; Virus
T100	Duration 2095 2096	4
T101	PROC 799 815	edad gestacional
#80	AnnotatorNotes T101	C4040272; Assessment of fetal gestational age; Health Care Activity
T103	PROC 783 787	peso
#81	AnnotatorNotes T103	C2985231; Body Weight Measurement; Diagnostic Procedure
T48	LIVB 43 51	neonatal
#82	AnnotatorNotes T48	C0021289; Infant, Newborn; Age Group
A1	Population_data T60 Age
A2	Assertion T6 Speculated
A3	Assertion T7 Speculated
A4	Assertion T8 Speculated
A5	Assertion T9 Speculated
A6	Assertion T10 Speculated
A7	Assertion T11 Speculated
A8	Assertion T21 Speculated
A9	Assertion T77 Negated
A10	Assertion T53 Speculated
A11	Assertion T24 Negated
A12	Assertion T25 Negated
A13	Assertion T18 Negated
A14	Assertion T26 Negated
A15	Assertion T27 Negated
A16	Assertion T52 Negated
A17	Assertion T108 Negated
A18	Assertion T68 Negated
A19	Population_data T41 Age
A20	Population_data T4 Age
#83	AnnotatorNotes T79	C1697794; Liquid Dosage Form; Biomedical or Dental Material
R1	Negation Arg1:T104 Arg2:T52	
T105	Neg_cue 2484 2486	no
T111	Quantifier_or_Qualifier 2491 2521	estadísticamente significativo
A21	Assertion T111 Negated
#84	AnnotatorNotes T111	C0237881; Statistical Significance; Quantitative Concept
R2	Negation Arg1:T105 Arg2:T111	
T112	Quantifier_or_Qualifier 2320 2350	estadísticamente significativo
A22	Assertion T112 Negated
#85	AnnotatorNotes T112	C0237881; Statistical Significance; Quantitative Concept
T113	Neg_cue 2313 2315	no
R3	Negation Arg1:T113 Arg2:T112	
R4	Negation Arg1:T76 Arg2:T77	
R5	Speculation Arg1:T78 Arg2:T53	
R6	Experiences Arg1:T77 Arg2:T53	
T114	Neg_cue 1586 1589	sin
T115	CONC 1590 1615	acción contra enterovirus
A23	Assertion T115 Negated
R7	Negation Arg1:T114 Arg2:T115	
#86	AnnotatorNotes T7	C0036690; Septicemia; Disease or Syndrome
T116	DISO 301 310	hepatitis
A24	Assertion T116 Speculated
#87	AnnotatorNotes T116	C0019158; Hepatitis; Disease or Syndrome
T117	Observation 394 409	morbimortalidad
A25	Assertion T117 Speculated
T118	Quantifier_or_Qualifier 389 393	alta
A26	Assertion T118 Speculated
R8	Has_Quantifier_or_Qualifier Arg1:T117 Arg2:T118	
R9	Negation Arg1:T76 Arg2:T24	
R10	Negation Arg1:T76 Arg2:T25	
R11	Negation Arg1:T76 Arg2:T18	
R12	Negation Arg1:T76 Arg2:T26	
R13	Negation Arg1:T76 Arg2:T27	
R14	Used_for Arg1:T58 Arg2:T1	
R15	Experiences Arg1:T48 Arg2:T2	
R16	Causes Arg1:T59 Arg2:T2	
R17	Experiences Arg1:T48 Arg2:T58	
R18	Has_Age Arg1:T60 Arg2:T61	
R19	Has_Age Arg1:T4 Arg2:T61	
R20	Speculation Arg1:T62 Arg2:T6	
R21	Causes Arg1:T63 Arg2:T6	
R22	Causes Arg1:T64 Arg2:T6	
R23	Experiences Arg1:T4 Arg2:T6	
R24	Experiences Arg1:T60 Arg2:T6	
R25	Speculation Arg1:T65 Arg2:T7	
R26	Before Arg1:T6 Arg2:T7	
R27	Before Arg1:T6 Arg2:T116	
R28	Before Arg1:T6 Arg2:T8	
R29	Before Arg1:T6 Arg2:T9	
R30	Before Arg1:T6 Arg2:T10	
R31	Before Arg1:T6 Arg2:T11	
R32	Speculation Arg1:T65 Arg2:T116	
R33	Speculation Arg1:T65 Arg2:T8	
R34	Speculation Arg1:T65 Arg2:T9	
R35	Speculation Arg1:T65 Arg2:T10	
R36	Speculation Arg1:T65 Arg2:T11	
R37	Overlap Arg1:T6 Arg2:T117	
R38	Experiences Arg1:T4 Arg2:T7	
R39	Experiences Arg1:T4 Arg2:T116	
R40	Experiences Arg1:T4 Arg2:T8	
R41	Experiences Arg1:T4 Arg2:T9	
R42	Experiences Arg1:T4 Arg2:T10	
R43	Experiences Arg1:T4 Arg2:T11	
R44	Experiences Arg1:T4 Arg2:T117	
R45	Experiences Arg1:T60 Arg2:T7	
R46	Experiences Arg1:T60 Arg2:T116	
R47	Experiences Arg1:T60 Arg2:T8	
R48	Experiences Arg1:T60 Arg2:T9	
R49	Experiences Arg1:T60 Arg2:T10	
R50	Experiences Arg1:T60 Arg2:T11	
R51	Experiences Arg1:T60 Arg2:T117	
R52	Before Arg1:T49 Arg2:T108	
R53	Before Arg1:T12 Arg2:T108	
R54	Before Arg1:T49 Arg2:T68	
R55	Before Arg1:T12 Arg2:T68	
R56	Location_of Arg1:T15 Arg2:T68	
R57	Negation Arg1:T69 Arg2:T108	
R58	Negation Arg1:T69 Arg2:T68	
R59	Overlap Arg1:T20 Arg2:T70	
T119	Result_or_Value 788 797	> 1.500 g
R60	Has_Result_or_Value Arg1:T103 Arg2:T119	
R61	Has_Duration_or_Interval Arg1:T71 Arg2:T72	
R62	Speculation Arg1:T73 Arg2:T21	
R63	Causes Arg1:T74 Arg2:T21	
R64	Location_of Arg1:T22 Arg2:T56	
R65	Location_of Arg1:T23 Arg2:T56	
T120	Quantifier_or_Qualifier 987 996	inminente
#88	AnnotatorNotes T120	C0332190; Impending; Temporal Concept
R67	Has_Quantifier_or_Qualifier Arg1:T53 Arg2:T120	
A27	Assertion T120 Speculated
R68	Causes Arg1:T109 Arg2:T24	
R69	Causes Arg1:T110 Arg2:T25	
T121	Observation 1064 1079	expuestos a VIH
#89	AnnotatorNotes T121	C0476549; Contact with and exposure to human immunodeficiency virus [HIV]; Finding
R70	Experiences Arg1:T77 Arg2:T121	
A28	Assertion T121 Negated
R71	Location_of Arg1:T13 Arg2:T27	
R72	Experiences Arg1:T77 Arg2:T24	
R73	Experiences Arg1:T77 Arg2:T26	
R74	Experiences Arg1:T77 Arg2:T27	
R75	Has_Duration_or_Interval Arg1:T54 Arg2:T80	
R76	Overlap Arg1:T28 Arg2:T80	
R77	Has_Route_or_Mode Arg1:T54 Arg2:T81	
R78	Has_Dose_or_Strength Arg1:T54 Arg2:T82	
R79	Has_Drug_Form Arg1:T54 Arg2:T79	
R80	Has_Drug_Form Arg1:T54 Arg2:T84	
R81	Has_Dose_or_Strength Arg1:T54 Arg2:T83	
R82	Has_Frequency Arg1:T54 Arg2:T85	
R83	Has_Duration_or_Interval Arg1:T54 Arg2:T86	
R84	Combined_with Arg1:T54 Arg2:T3	
T122	ANAT 1346 1359	leche materna
#90	AnnotatorNotes T122	C1556060; Specimen Type - Breast milk; Body Substance
R85	Combined_with Arg1:T54 Arg2:T122	
T123	Route 1371 1379	por boca
#91	AnnotatorNotes T123	C1527415; Oral Route of Drug administration; Functional Concept
R86	Has_Route_or_Mode Arg1:T54 Arg2:T123	
R87	Used_for Arg1:T88 Arg2:T54	
T124	Quantifier_or_Qualifier 1424 1432	seriados
R88	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T124	
R89	Location_of Arg1:T31 Arg2:T30	
R90	Location_of Arg1:T32 Arg2:T30	
R91	Location_of Arg1:T55 Arg2:T30	
R92	Location_of Arg1:T33 Arg2:T30	
R93	Experiences Arg1:T89 Arg2:T34	
T125	Quantifier_or_Qualifier 1537 1542	otros
#92	AnnotatorNotes T125	C0205394; Other; Qualitative Concept
R94	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T125	
R95	Experiences Arg1:T89 Arg2:T35	
R96	Experiences Arg1:T89 Arg2:T5	
R97	Experiences Arg1:T89 Arg2:T36	
R98	Experiences Arg1:T89 Arg2:T37	
R99	Has_Route_or_Mode Arg1:T37 Arg2:T93	
R100	Experiences Arg1:T89 Arg2:T38	
R101	Experiences Arg1:T89 Arg2:T14	
T126	PROC 1709 1716	estudio
#93	AnnotatorNotes T126	C0681814; research study; Research Activity
R102	Has_Duration_or_Interval Arg1:T126 Arg2:T94	
R103	Has_Duration_or_Interval Arg1:T39 Arg2:T96	
R104	Experiences Arg1:T41 Arg2:T40	
R105	Experiences Arg1:T41 Arg2:T42	
R106	Causes Arg1:T97 Arg2:T42	
R107	Causes Arg1:T90 Arg2:T42	
T127	Observation 1970 1986	buena tolerancia
T128	Result_or_Value 2001 2015	negativización
#94	AnnotatorNotes T128	C0205160; Negative; Finding
T129	CONC 1991 2015	tiempo de negativización
R109	Has_Duration_or_Interval Arg1:T129 Arg2:T100	
R110	Has_Duration_or_Interval Arg1:T129 Arg2:T98	
R111	Before Arg1:T45 Arg2:T128	
R112	Before Arg1:T46 Arg2:T128	
T130	CONC 2113 2132	intención de tratar
#95	AnnotatorNotes T130	C1292734; Treatment intent; Functional Concept
T131	CONC 2167 2177	mortalidad
#96	AnnotatorNotes T131	C0026565; Mortality Vital Statistics; Quantitative Concept
T132	CONC 2368 2377	sobrevida
R113	Used_for Arg1:T51 Arg2:T50	
R114	Experiences Arg1:T102 Arg2:T50	
R115	Experiences Arg1:T102 Arg2:T52	
#97	AnnotatorNotes T118	C0205250; High; Qualitative Concept
R116	Overlap Arg1:T19 Arg2:T127	
R117	Overlap Arg1:T43 Arg2:T127	
#98	AnnotatorNotes T127	C5684674; patient tolerated procedure well; Finding
T133	Quantifier_or_Qualifier 2178 2184	global
#99	AnnotatorNotes T133	C2348867; Global; Qualitative Concept
R66	Has_Quantifier_or_Qualifier Arg1:T131 Arg2:T133	
#100	AnnotatorNotes T132	C0220921; survival aspects; Functional Concept
R108	Has_Quantifier_or_Qualifier Arg1:T132 Arg2:T111	
R118	Speculation Arg1:T65 Arg2:T118	
R119	Speculation Arg1:T65 Arg2:T117	
#101	AnnotatorNotes T12	C0003451; Antiviral Agents; Pharmacologic Substance
A29	Experiencer T99 Patient
A30	Experiencer T102 Patient
A31	Experiencer T41 Patient
A32	Experiencer T95 Patient
A33	Experiencer T89 Patient
A34	Experiencer T48 Patient
A35	Population_data T48 Age
A36	Experiencer T4 Patient
A37	Experiencer T60 Patient
A38	Experiencer T77 Patient
R120	Has_Result_or_Value Arg1:T44 Arg2:T128	
T134	Observation 1954 1957	EV+
#102	AnnotatorNotes T134	C2748323; Enterovirus test positive; Laboratory or Test Result | C4698382; Positive for Enteroviruses; Laboratory or Test Result
T135	Observation 1932 1935	EV+
#103	AnnotatorNotes T135	C2748323; Enterovirus test positive; Laboratory or Test Result | C4698382; Positive for Enteroviruses; Laboratory or Test Result
T136	Observation 1886 1889	EV+
#104	AnnotatorNotes T136	C2748323; Enterovirus test positive; Laboratory or Test Result | C4698382; Positive for Enteroviruses; Laboratory or Test Result
T137	Observation 2257 2260	EV+
#105	AnnotatorNotes T137	C2748323; Enterovirus test positive; Laboratory or Test Result | C4698382; Positive for Enteroviruses; Laboratory or Test Result
R121	Experiences Arg1:T99 Arg2:T137	
